Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS

NCT04132375 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Due to COVID pandemia enrolment was stopped on 20March2020

Conditions

Bloody Diarrhea
STEC, Unspecified
Hemolytic-Uremic Syndrome
Pediatric Kidney Disease

Interventions

DRUG: INM004
DRUG: Placebo

Sponsor

Inmunova S.A.

Collaborators

[object Object]